OWC and Sheba Medical Center Extend Contract for Medical Cannabis Trials to Treat Fibromyalgia

OWC Pharmaceutical Research Corp. (OTC: OWCP), developer of cannabinoid-based therapies targeting a wide variety of different medical indications, recently announced the extension of its contract with Sheba Academic Medical Center to further conduct clinical trials targeting fibromyalgia to help advance better treatments to patients through medical cannabis. “While fibromyalgia is a chronic widespread disease impacting the daily lives…

The post OWC and Sheba Medical Center Extend Contract for Medical Cannabis Trials to Treat Fibromyalgia appeared first on Marijuana Index.